Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Crown Electrokinetics Corp.

Change company Symbol lookup

Select an option...

CRKN Crown Electrokinetics Corp.

CAE CAE Inc

YMAB Y-mAbs Therapeutics Inc

VINE Fresh Vine Wine Inc

BURU NUBURU Inc

AMPX Amprius Technologies Inc

CKPT Checkpoint Therapeutics Inc

IR Ingersoll Rand Inc

AVID Avid Technology Inc

VTSI VirTra Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Materials : Chemicals | Small Cap Growth

Company profile

Crown Electrokinetics Corp. develops and sells optical switching film, which can be embedded between sheets of glass or applied to the surface of glass, or other rigid substrates, such as acrylic, to electronically control opacity (DynamicTint). Its technology allows a transition between clear and dark and can be applied to a range of windows, including commercial buildings, automotive sunroofs, and residential skylights and windows. Its electrokinetic (EK) technology is derived from ink and microfluidic technology. Its EK film technology utilizes nanometer-sized pigment particles that are electrically charged and suspended in a liquid that is sandwiched between two clear substrates that are coated with a transparent conductor oxide (TCO) film. Its plastic films are manufactured using roll-to-roll (R2R) processing equipment. Its DynamicTint Smart Glass Insert is specifically designed for retrofitting in the domestic and international commercial real estate install base.

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

4:41 pm ET January 19, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) advanced 2.23% to $73.75 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.76% to 3,898.85 and Dow Jones Industrial Average falling 0.76% to 33,044.56. The stock's rise snapped a two-day losing streak. Bristol Myers Squibb Co. closed $7.69 short of its 52-week high ($81.44), which the company reached on December 1st.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.14% to $169.53, Pfizer Inc. (PFE) fell 0.09% to $44.96, and Abbott Laboratories (ABT) rose 0.26% to $111.80. Trading volume (9.4 M) eclipsed its 50-day average volume of 9.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 19, 2023.

(END) Dow Jones Newswires

January 19, 2023 16:41 ET (21:41 GMT)